HealthEquity EVP receives stock awards

HEALTHEQUITY, INC. executive vice president and general counsel Delano Ladd reported two stock-based compensation transactions involving the company’s common stock.

Rhea-AI Filing Summary

HEALTHEQUITY, INC. executive vice president and general counsel Delano Ladd reported two stock-based compensation transactions involving the company’s common stock. On March 25, 2026, he acquired 15,157 restricted stock units as a grant and 20,451 restricted stock units vested and converted into shares at no cash cost to him.

Each restricted stock unit represents the right to receive one share of common stock. The newly granted 15,157 units will vest 25% on April 1, 2027, with 6.25% vesting on the first day of each calendar quarter for the following twelve quarters. After these awards, Ladd directly holds 108,848 shares.

Insider Trade Summary

Grant/Award: 35,608 shares

Grant/Award 2 txns

Insider Ladd Delano

Role EVP, General Counsel

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	15,157	$0.00	$0.00
Grant/Award	Common Stock	20,451	$0.00	$0.00

Holdings After Transaction: Common Stock — 108,848 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2027. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2027.
2. F2. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 20,451 shares on March 25, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HEALTHEQUITY (HQY) executive Delano Ladd report in this Form 4?

Delano Ladd reported two stock-based compensation acquisitions of HEALTHEQUITY common stock. He received a grant of 15,157 restricted stock units and had 20,451 restricted stock units vest into shares, all recorded as equity awards rather than open-market purchases.

How many HEALTHEQUITY (HQY) shares does Delano Ladd hold after these transactions?

Following the reported transactions, Delano Ladd directly holds 108,848 shares of HEALTHEQUITY common stock. This total reflects the impact of both the new restricted stock unit grant and the vesting of 20,451 restricted stock units on March 25, 2026.

Were Delano Ladd’s HEALTHEQUITY (HQY) Form 4 transactions open-market buys or compensation awards?

The transactions were compensation awards, not open-market buys. Both entries are coded as grants or awards (code A), representing restricted stock units granted and vesting into common shares at a price of $0.00 per share for the reporting executive.

What are the vesting terms of Delano Ladd’s new HEALTHEQUITY restricted stock units?

The 15,157 newly granted restricted stock units vest over time. Twenty-five percent vest on April 1, 2027, and 6.25% vest on the first day of each calendar quarter for the twelve quarters following April 1, 2027, assuming continued service conditions are met.

What does each HEALTHEQUITY (HQY) restricted stock unit granted to Delano Ladd represent?

Each restricted stock unit represents a contingent right to receive one share of HEALTHEQUITY common stock. The units convert into actual shares as they vest according to the specified schedule, providing equity-based compensation without upfront cash payment by the executive.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 06:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ladd Delano

(Last) (First) (Middle)

C/O HEALTHEQUITY, INC.

15 W. SCENIC POINTE DR., STE. 100

(Street)

DRAPER UTAH 84020

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/25/2026		A		15,157(1)	A	$0	88,397	D
Common Stock	03/25/2026		A		20,451(2)	A	$0	108,848	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2027. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2027.

2. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 20,451 shares on March 25, 2026.

	/s/ Delano Ladd	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)